Global Digital Pharma Solution 麻豆原创 Research Report 2023

Publication ID:

PB510230418

Publication Date:

October 2, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Digital Pharma Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Digital Pharma Solution market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Digital Pharma Solution market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
GE Healthcare
Syntegon Technology
Zuellig Pharma Holdings
Interactive Pharma Solutions
IBM Watson Health
Euris
Atos
MphaR
Medocity
e-Zest Solutions
Siemens Healthcare
Hexaware Technologies
Segment by Type
Cloud-based
On-premise
Segment by Application
Hospitals
Health Systems
Pharmaceutical Factory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Digital Pharma Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Digital Pharma Solution 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cloud-based
1.2.3 On-premise
1.3 麻豆原创 by Application
1.3.1 Global Digital Pharma Solution 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Health Systems
1.3.4 Pharmaceutical Factory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Pharma Solution 麻豆原创 Perspective (2018-2029)
2.2 Digital Pharma Solution Growth Trends by Region
2.2.1 Global Digital Pharma Solution 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Digital Pharma Solution Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Digital Pharma Solution Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Digital Pharma Solution 麻豆原创 Dynamics
2.3.1 Digital Pharma Solution Industry Trends
2.3.2 Digital Pharma Solution 麻豆原创 Drivers
2.3.3 Digital Pharma Solution 麻豆原创 Challenges
2.3.4 Digital Pharma Solution 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Pharma Solution Players by Revenue
3.1.1 Global Top Digital Pharma Solution Players by Revenue (2018-2023)
3.1.2 Global Digital Pharma Solution Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Digital Pharma Solution 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Pharma Solution Revenue
3.4 Global Digital Pharma Solution 麻豆原创 Concentration Ratio
3.4.1 Global Digital Pharma Solution 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Pharma Solution Revenue in 2022
3.5 Digital Pharma Solution Key Players Head office and Area Served
3.6 Key Players Digital Pharma Solution Product Solution and Service
3.7 Date of Enter into Digital Pharma Solution 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Pharma Solution Breakdown Data by Type
4.1 Global Digital Pharma Solution Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Digital Pharma Solution Forecasted 麻豆原创 Size by Type (2024-2029)
5 Digital Pharma Solution Breakdown Data by Application
5.1 Global Digital Pharma Solution Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Digital Pharma Solution Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Digital Pharma Solution 麻豆原创 Size (2018-2029)
6.2 North America Digital Pharma Solution 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Digital Pharma Solution 麻豆原创 Size by Country (2018-2023)
6.4 North America Digital Pharma Solution 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Pharma Solution 麻豆原创 Size (2018-2029)
7.2 Europe Digital Pharma Solution 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Digital Pharma Solution 麻豆原创 Size by Country (2018-2023)
7.4 Europe Digital Pharma Solution 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Pharma Solution 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Digital Pharma Solution 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Digital Pharma Solution 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Digital Pharma Solution 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Pharma Solution 麻豆原创 Size (2018-2029)
9.2 Latin America Digital Pharma Solution 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Digital Pharma Solution 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Digital Pharma Solution 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Pharma Solution 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Digital Pharma Solution 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Digital Pharma Solution 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Digital Pharma Solution 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Digital Pharma Solution Introduction
11.1.4 GE Healthcare Revenue in Digital Pharma Solution Business (2018-2023)
11.1.5 GE Healthcare Recent Development
11.2 Syntegon Technology
11.2.1 Syntegon Technology Company Detail
11.2.2 Syntegon Technology Business Overview
11.2.3 Syntegon Technology Digital Pharma Solution Introduction
11.2.4 Syntegon Technology Revenue in Digital Pharma Solution Business (2018-2023)
11.2.5 Syntegon Technology Recent Development
11.3 Zuellig Pharma Holdings
11.3.1 Zuellig Pharma Holdings Company Detail
11.3.2 Zuellig Pharma Holdings Business Overview
11.3.3 Zuellig Pharma Holdings Digital Pharma Solution Introduction
11.3.4 Zuellig Pharma Holdings Revenue in Digital Pharma Solution Business (2018-2023)
11.3.5 Zuellig Pharma Holdings Recent Development
11.4 Interactive Pharma Solutions
11.4.1 Interactive Pharma Solutions Company Detail
11.4.2 Interactive Pharma Solutions Business Overview
11.4.3 Interactive Pharma Solutions Digital Pharma Solution Introduction
11.4.4 Interactive Pharma Solutions Revenue in Digital Pharma Solution Business (2018-2023)
11.4.5 Interactive Pharma Solutions Recent Development
11.5 IBM Watson Health
11.5.1 IBM Watson Health Company Detail
11.5.2 IBM Watson Health Business Overview
11.5.3 IBM Watson Health Digital Pharma Solution Introduction
11.5.4 IBM Watson Health Revenue in Digital Pharma Solution Business (2018-2023)
11.5.5 IBM Watson Health Recent Development
11.6 Euris
11.6.1 Euris Company Detail
11.6.2 Euris Business Overview
11.6.3 Euris Digital Pharma Solution Introduction
11.6.4 Euris Revenue in Digital Pharma Solution Business (2018-2023)
11.6.5 Euris Recent Development
11.7 Atos
11.7.1 Atos Company Detail
11.7.2 Atos Business Overview
11.7.3 Atos Digital Pharma Solution Introduction
11.7.4 Atos Revenue in Digital Pharma Solution Business (2018-2023)
11.7.5 Atos Recent Development
11.8 MphaR
11.8.1 MphaR Company Detail
11.8.2 MphaR Business Overview
11.8.3 MphaR Digital Pharma Solution Introduction
11.8.4 MphaR Revenue in Digital Pharma Solution Business (2018-2023)
11.8.5 MphaR Recent Development
11.9 Medocity
11.9.1 Medocity Company Detail
11.9.2 Medocity Business Overview
11.9.3 Medocity Digital Pharma Solution Introduction
11.9.4 Medocity Revenue in Digital Pharma Solution Business (2018-2023)
11.9.5 Medocity Recent Development
11.10 e-Zest Solutions
11.10.1 e-Zest Solutions Company Detail
11.10.2 e-Zest Solutions Business Overview
11.10.3 e-Zest Solutions Digital Pharma Solution Introduction
11.10.4 e-Zest Solutions Revenue in Digital Pharma Solution Business (2018-2023)
11.10.5 e-Zest Solutions Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Detail
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Digital Pharma Solution Introduction
11.11.4 Siemens Healthcare Revenue in Digital Pharma Solution Business (2018-2023)
11.11.5 Siemens Healthcare Recent Development
11.12 Hexaware Technologies
11.12.1 Hexaware Technologies Company Detail
11.12.2 Hexaware Technologies Business Overview
11.12.3 Hexaware Technologies Digital Pharma Solution Introduction
11.12.4 Hexaware Technologies Revenue in Digital Pharma Solution Business (2018-2023)
11.12.5 Hexaware Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

GE Healthcare
Syntegon Technology
Zuellig Pharma Holdings
Interactive Pharma Solutions
IBM Watson Health
Euris
Atos
MphaR
Medocity
e-Zest Solutions
Siemens Healthcare
Hexaware Technologies

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.